SMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapy.
about
Polyketide synthase chemistry does not direct biosynthetic divergence between 9- and 10-membered enediynesProtein-polymer nano-machines. Towards synthetic control of biological processesDrug Carrier for Photodynamic Cancer TherapyPolymer nanogels: a versatile nanoscopic drug delivery platformA polymeric prodrug of 5-fluorouracil-1-acetic acid using a multi-hydroxyl polyethylene glycol derivative as the drug carrierMagnetic Nanoparticle Facilitated Drug Delivery for Cancer Therapy with Targeted and Image-Guided ApproachesBrain delivery of proteins via their fatty acid and block copolymer modificationsTumor vascular permeability to a nanoprobe correlates to tumor-specific expression levels of angiogenic markers.Stabilization of the nitric oxide (NO) prodrugs and anticancer leads, PABA/NO and Double JS-K, through incorporation into PEG-protected nanoparticlesEfficient pH dependent drug delivery to target cancer cells by gold nanoparticles capped with carboxymethyl chitosanLapatinib-incorporated lipoprotein-like nanoparticles: preparation and a proposed breast cancer-targeting mechanism.Enediyne antitumor antibiotic maduropeptin biosynthesis featuring a C-methyltransferase that acts on a CoA-tethered aromatic substrate.PEGylation of bovine serum albumin using click chemistry for the application as drug carriers.Cold instability of aponeocarzinostatin and its stabilization by labile chromophore.Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology.Intravenous delivery of targeted liposomes to amyloid-β pathology in APP/PSEN1 transgenic mice.The uptake of N-(2-hydroxypropyl)-methacrylamide based homo, random and block copolymers by human multi-drug resistant breast adenocarcinoma cellsTargeted nanogels: a versatile platform for drug delivery to tumorsDevelopment of a novel DDS for site-specific PEGylated proteins.Anti-angiogenic peptides for cancer therapeuticsSynthesis and evaluation of poly(styrene-co-maleic acid) micellar nanocarriers for the delivery of tanespimycin.Utilization of monoclonal antibody-targeted nanomaterials in the treatment of cancer.RAFT-synthesized graft copolymers that enhance pH-dependent membrane destabilization and protein circulation timesPolymer genomics: an insight into pharmacology and toxicology of nanomedicinesDextran-conjugated vascular endothelial growth factor receptor antibody for in vivo melanoma xenografted mouse imaging.Protein and peptide parenteral controlled delivery.Stimuli responsive polymers for biomedical applications.Functionalization of Carbon Nanomaterial Surface by Doxorubicin and Antibodies to Tumor Markers.Self-Assembly of Temperature-Responsive Protein-Polymer Bioconjugates.Amphiphilic graft copolymer based on poly(styrene-co-maleic anhydride) with low molecular weight polyethylenimine for efficient gene deliveryLong-circulating polymeric nanovectors for tumor-selective gene delivery.The styrene-maleic acid copolymer: a versatile tool in membrane researchAnionic clay as the drug delivery vehicle: tumor targeting function of layered double hydroxide-methotrexate nanohybrid in C33A orthotopic cervical cancer modelAffinity transfer by CDR grafting on a nonimmunoglobulin scaffoldCancer nanomedicines: so many papers and so few drugs!Issues related to targeted delivery of proteins and peptides.Regiospecific O-methylation of naphthoic acids catalyzed by NcsB1, an O-methyltransferase involved in the biosynthesis of the enediyne antitumor antibiotic neocarzinostatinTargeted pharmaceutical nanocarriers for cancer therapy and imagingDevelopment of octreotide-conjugated polymeric prodrug of bufalin for targeted delivery to somatostatin receptor 2 overexpressing breast cancer in vitro and in vivo.Polymeric micelles for drug targeting.
P2860
Q24623828-5B4343FF-056F-4AEF-A5AA-B8EE4D633648Q24795142-1E576923-AC8B-416E-A29D-6F682B5E5B91Q26782780-46EBA04F-B72D-4E4D-BA0F-9B801A2E3F7EQ27014176-33CAFC21-D455-4E2E-A10B-31A4A5C7FB12Q28544909-A4C39919-17D1-4E77-A5E8-448A9301004EQ30354223-31EE4755-9B19-4BA1-8BB7-8C08011A77CFQ30354932-BC548190-39AF-4062-862C-D737A27C7E7BQ33464944-9DE94E1A-58F6-45CF-8565-0B8E22502C29Q33624748-141DFDAB-E380-4E2A-9999-9416862BCC1DQ33755737-E06EC625-7D97-4BB7-BC10-8C1A5DA60941Q33861915-4776C377-FF73-4003-B70E-91E0D7460A9CQ34112660-E877D20F-4FE0-4809-9C9E-038BA5381C83Q34139643-3AB39324-7979-4C1D-AA82-08A4FB783FCCQ34190719-BDE0EB00-B1FB-4F87-B947-A6D5710AC00DQ34447986-61E89CB2-9606-4145-A925-35F9E3E75529Q34465222-ED632BF2-AE33-434D-AAF7-C0317D9400C7Q34946461-737B8383-87F7-4D7E-9152-7A80BDED87E0Q35038164-5C2E5B43-56E3-4D58-B289-EDB8DE9521F6Q35040200-CE58A1D6-B897-4D61-8ABF-7EE89FC48A62Q35043016-39F6B2CE-0760-4EC5-8AEA-CAAD143743EAQ35375097-1E073D1F-11A0-4143-B526-802C0432C74DQ35578037-E856E19B-16D4-4DA4-881A-12C2FE4ABBEFQ35739852-BE6A3D48-4CB4-4113-89AC-1F209BA9522CQ35754353-0EA63DAA-14AD-4964-8EFA-42A9AF9D1800Q35831897-C7508879-E650-4EB6-A858-6BC23AA5287BQ35842593-5E183C6C-4F6A-48C5-BE0E-7B296A7045E3Q36052138-5A06C962-29F4-4C4D-B040-FB6843C0E64DQ36064150-6869CF98-6FD2-42BA-8CA0-8E1BB59D1CFBQ36081046-D43B71C3-3B96-40F3-98E7-F94285BB4DF2Q36247150-D7B6CA3A-1E97-4AC9-AB8B-4474FDC939CDQ36314788-466715AE-3DED-4F18-B67F-549E7604064CQ36422182-FFA7667B-5DBD-4F9E-99C5-10604F6AAAB9Q36498730-08B58B07-5378-4F02-AC3E-64457990A7F8Q36519322-159D1FD7-67CD-484E-9554-F1EE271E4114Q36589023-A77F8462-52E1-4387-9B14-355D929654B6Q36616311-4C0DE543-33AC-4E17-8FD1-6E2554D5EBD1Q36662723-67EE2459-E31D-4857-B41E-6E36D134D3B8Q36871933-55769F36-3874-42FD-9214-A2854217C2E1Q36944149-DC0BE0B7-BBA3-4C28-8E2C-C650DD7608E0Q36985038-18028756-938A-42C6-B46D-CCCD2D2A5717
P2860
SMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapy.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
SMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapy.
@ast
SMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapy.
@en
SMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapy.
@nl
type
label
SMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapy.
@ast
SMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapy.
@en
SMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapy.
@nl
prefLabel
SMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapy.
@ast
SMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapy.
@en
SMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapy.
@nl
P1476
SMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapy.
@en
P2093
P304
P356
10.1016/S0169-409X(00)00134-4
P407
P577
2001-03-01T00:00:00Z